Literature DB >> 12498987

Resistance to hyperoxia with heme oxygenase-1 disruption: role of iron.

Phyllis A Dennery1, Gary Visner, Y i-Hao Weng, Xuandai Nguyen, Fuhua Lu, Dani Zander, Guang Yang.   

Abstract

In many models, a protective role for heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme degradation, has been demonstrated. Also, HO-1 null mice (KO) are more susceptible to inflammation and hypoxia and transplant rejection. Nonetheless, their response to hyperoxia (> 95% O(2)) has not yet been evaluated. Surprisingly, after acute hyperoxic exposure, KO had significantly decreased markers of lung oxidative injury and survived chronic hyperoxia as well as wild-type (WT) controls. Disrupted HO-1 expression was associated with decreased lung reactive iron and iron-associated proteins, decreased NADPH cytochrome cp450 reductase activity, and decreased lung peroxidase activity compared to WT. Injection of tin protoporphyrin, an inhibitor of HO, in the WT decreased acute hyperoxic lung injury, whereas transduction of human HO-1 in the KO reversed the relative protection of the KO to acute injury and worsened hyperoxic survival. This suggests that disruption of HO-1 protects against hyperoxia by diminishing the generation of toxic reactive intermediates in the lung via iron and H(2)O(2).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12498987     DOI: 10.1016/s0891-5849(02)01295-9

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  26 in total

1.  TLR signaling prevents hyperoxia-induced lung injury by protecting the alveolar epithelium from oxidant-mediated death.

Authors:  Megan N Ballinger; Michael W Newstead; Xianying Zeng; Urvashi Bhan; Jeffrey C Horowitz; Bethany B Moore; David J Pinsky; Richard A Flavell; Theodore J Standiford
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.

Authors:  Jian Wang; Sylvain Doré
Journal:  Brain       Date:  2007-06       Impact factor: 13.501

3.  Heme oxygenase activity and hemoglobin neurotoxicity are attenuated by inhibitors of the MEK/ERK pathway.

Authors:  Jing Chen-Roetling; Zhi Li; Mai Chen; Olatilewa O Awe; Raymond F Regan
Journal:  Neuropharmacology       Date:  2009-02-06       Impact factor: 5.250

4.  Hemoglobin neurotoxicity is attenuated by inhibitors of the protein kinase CK2 independent of heme oxygenase activity.

Authors:  Jing Chen-Roetling; Zhi Li; Raymond F Regan
Journal:  Curr Neurovasc Res       Date:  2008-08       Impact factor: 1.990

5.  HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells.

Authors:  Karen E Iles; Dale A Dickinson; Amanda F Wigley; Nathan E Welty; Volker Blank; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2005-04-09       Impact factor: 7.376

Review 6.  Heme oxygenase in neonatal lung injury and repair.

Authors:  Phyllis A Dennery
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

7.  Enhanced translation of heme oxygenase-2 preserves human endothelial cell viability during hypoxia.

Authors:  Jeff Z He; J J David Ho; Sheena Gingerich; David W Courtman; Philip A Marsden; Michael E Ward
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

8.  Heme Attenuation Ameliorates Irritant Gas Inhalation-Induced Acute Lung Injury.

Authors:  Saurabh Aggarwal; Adam Lam; Subhashini Bolisetty; Matthew A Carlisle; Amie Traylor; Anupam Agarwal; Sadis Matalon
Journal:  Antioxid Redox Signal       Date:  2015-12-14       Impact factor: 8.401

Review 9.  The role of heme oxygenase-1 in pulmonary disease.

Authors:  Laura E Fredenburgh; Mark A Perrella; S Alex Mitsialis
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-15       Impact factor: 6.914

10.  Increased expression of ferritin in cerebral cortex after human traumatic brain injury.

Authors:  Huan-Dong Liu; Wei Li; Zhen-Rui Chen; Meng-Liang Zhou; Zong Zhuang; Ding-Ding Zhang; Lin Zhu; Chun-Hua Hang
Journal:  Neurol Sci       Date:  2012-10-19       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.